Neural Tube Defects

Neural tube defects are a group of congenital anomalies that arise when the neural tube — the embryonic precursor of the brain and spinal cord — fails to close completely during the fourth week of development. They include anencephaly, encephalocele, and the various forms of spina bifida, and they are among the most common and best-studied structural malformations of the central nervous system.

Definition

Neural tube defects are congenital malformations resulting from failure of the neural tube to close during the third to fourth week of development; failure at the cranial end produces anencephaly or encephalocele, while failure at the caudal end produces the open and closed forms of spina bifida.

Scope

This entry describes the embryological basis of neural tube defects, their principal clinical forms, the genetic and environmental factors that contribute to them, and the strong evidence that periconceptional folic acid reduces their occurrence. It is reference and educational material on the developmental origins and epidemiology of these defects, not a source of diagnostic protocols, dosing, or individualised management advice.

Core questions

• Which developmental events must occur for the neural tube to close, and how does their failure produce specific defects?
• What genetic and environmental factors raise the risk of neural tube defects?
• How and why does periconceptional folic acid reduce the risk of these defects?
• What are the structural differences among anencephaly, encephalocele, and the forms of spina bifida?

Key concepts

• Primary and secondary neurulation
• Cranial and caudal neuropores
• Anencephaly, encephalocele, and spina bifida
• Open versus closed dysraphism
• Folate-sensitive versus folate-resistant defects
• Multifactorial gene-environment causation

Key theories

Closure-failure model of neurulation defects

Primary neurulation requires the neural plate to elevate, fold, and fuse along the future neuraxis at defined initiation sites; failure of fusion at the cranial neuropore leads to anencephaly and at the caudal neuropore to open spina bifida, so the anatomical level of a defect reflects where and when closure failed.

Mechanisms

During primary neurulation the flat neural plate elevates into folds that meet and fuse in the dorsal midline, converting the open neural groove into a closed tube; closure proceeds from initiation sites toward the cranial and caudal neuropores, which seal last. When fusion fails at the cranial end, the forebrain is left exposed and degenerates, producing anencephaly; failure at the caudal end leaves the spinal cord and meninges exposed, producing open spina bifida (myelomeningocele). The process depends on coordinated cell proliferation, apoptosis, and cytoskeletal bending, and is sensitive to folate one-carbon metabolism, which is why folate status modifies risk. Causation is multifactorial, combining susceptibility genes with environmental and nutritional influences.

Clinical relevance

Because neural tube closure is complete very early in gestation — often before pregnancy is recognised — the developmental window for prevention precedes most prenatal care, which is the rationale behind periconceptional folic acid strategies. The defects vary widely in severity, from the uniformly fatal anencephaly to forms of spina bifida compatible with long survival but associated with motor, urinary, and neurological consequences. This entry describes these relationships for educational purposes and is not a basis for individual screening, counselling, or treatment decisions.

Epidemiology

Neural tube defects are among the most common serious congenital anomalies of the central nervous system, with birth prevalence varying substantially by geography, ancestry, and folate status of the population. Randomised evidence established that periconceptional folic acid markedly reduces both the recurrence and the first occurrence of these defects, prompting folic acid fortification and supplementation policies in many countries.

Evidence & guidelines

The preventive evidence base is unusually strong for a congenital anomaly: the MRC Vitamin Study demonstrated that folic acid reduced recurrence in high-risk pregnancies, and Czeizel and Dudás showed reduction of first occurrence in a general population, together underpinning folic acid recommendations worldwide. For affected pregnancies, the MOMS trial provided randomised evidence comparing prenatal and postnatal repair of myelomeningocele. Contemporary reviews synthesise the developmental biology, risk factors, and clinical outcomes.

History

The association between maternal nutrition and neural tube defects emerged through observational and intervention studies from the 1960s onward, culminating in the randomised MRC Vitamin Study (1991) and the Czeizel and Dudás trial (1992), which together established folic acid as preventive and reshaped public health policy. More recently, the MOMS trial (2011) brought randomised evidence to the question of fetal versus postnatal surgical repair of myelomeningocele.

Debates

What is the optimal balance and reach of folic acid fortification?

Although periconceptional folic acid clearly reduces neural tube defects, the appropriate fortification levels, target populations, and the residual burden of folate-resistant defects remain matters of ongoing public health discussion.

When should myelomeningocele be repaired?

The MOMS trial showed benefits of prenatal repair on some neurological outcomes but at the cost of maternal and obstetric risks, so the choice between prenatal and postnatal surgery continues to be weighed case by case.

Key figures

• Andrew J. Copp
• Nicholas D. E. Greene
• Andrew E. Czeizel
• N. Scott Adzick

Seminal works

• mrc-1991
• czeizel-1992
• copp-2015
• adzick-2011

Frequently asked questions

Why does folic acid taken before pregnancy reduce neural tube defects?

The neural tube closes very early, in about the fourth week after conception, and folate supports the one-carbon metabolism needed for the rapid cell division of neurulation; randomised trials showed that adequate periconceptional folic acid reduces both recurrence and first occurrence of these defects.

What is the difference between anencephaly and spina bifida?

Both result from failure of neural tube closure, but anencephaly follows failure of closure at the cranial end, leaving the forebrain unformed and being uniformly fatal, whereas spina bifida follows failure at the caudal end, affecting the spinal cord and its coverings.